Table 1 Identification of anaerobic Gram positive bacterial isolates by conventional 16S rRNA gene sequencing, commercially available bacterial identification systems, and the Microseq 500 16S rDNA bacterial identification system.
Patient/strain no. | Patient characteristics | Conventional 16S rRNA gene sequencing | Commercially available bacterial identification systems | MicroSeq 500 16S rDNA bacterial identification system | ||||
---|---|---|---|---|---|---|---|---|
Sex/age* | Diagnosis | Vitek ANI | RapID ANA II | API 20A | Identity | % Difference between isolate sequences and closest match | ||
1 | M/1 m | Pseudobacteraemia | Bifidobacterium pseudocatenulatum/catenulatum | Unidentified | >99.9% Clostridium perfringens | 92% Eubacterium lentum, 8% Actinomyces viscosus | B catenulatum | 1.4 |
2 | F/94 | Pseudobacteraemia | Clostridium barati | Unidentified | 99.5% C barati | 68% Actinomyces israelii, 17% Bifidobacterium sp. | C barati | 0 |
3 | M/1 m | Necrotising enterocolitis | Clostridium difficile | 94% C difficile | >99.9% C difficile | 99.9% C difficile | C difficile | 0 |
4 | F/75 | Primary bacteraemia | Clostridium disporicum | 99% C barati | >99.9% C barati | 94% E lentum, 3% A viscosus | Clostridium paraputrificum | 3.3 |
5 | F/77 | Pseudobacteraemia | Clostridium indolis | 89% Clostridium tetani | 73% Clostridium limosum, 16% Clostridium novyi A, 12% C tetani | Unidentified | Clostridium innocuum | 8.7 |
6 | M/80 | Pseudobacteraemia | C innocuum | 61% Corynebacterium jeikeium, 37% Lactobacillus jensenii | 74% C innocuum, 26% Clostridium subterminale | 98% C innocuum | Eubacterium dolichum | 8.0 |
7 | F/24 | Pseudobacteraemia | Clostridium orbiscindens | 45% C subterminale, 39% Clostriduim histolyticum, 11% C jeikeium | 67% C tetani, 19% novyi A, 12% E lentum | 94% E lentum, 3% A viscosus | Ruminococcus productus | 18.4 |
8 | M/6 m | Intussusception | C paraputrificum | 81% Clostridium septicum | 77% C septicum, 23% C paraputrificum | 80% C paraputrificum, 19% C barati | C paraputrificum | 0 |
9 | F/44 | Acute cholangitis | Clostridium perfringens | 99% C perfringens | >99.9% C perfringens | 97% C perfringens, 3% Actinomyces naeslundii | C perfringens | 0.2 |
10 | M/54 | Primary bacteraemia | Clostridium ramosum | 83% C barati, 11% Lactobacillus catenaforme | >99.9% C ramosum | 96% C ramosum, 3% Bifidobacterium sp. | C ramosum | 0 |
11 | F/40 | Neutropenic fever | C septicum | 54% C septicum, 42% C paraputrificum | >99.9% C septicum | 99.9% C septicum | Clostridium tertium | 2.6 |
12 | F/45 | Pseudobacteraemia | Clostridium sporosphaeroides | Unidentified | 67% C tetani, 19% C novyi A, 12% E lentum | Unidentified | C sporosphaeroides | 10.6 |
13 | F/78 | Pseudobacteraemia | C tertium | 71% C tertium, 22% Clostridium clostridiforme | 99.9% C barati | 90% C tertium, 7% Bifidobacterium sp. | C tertium | 0 |
14 | F/87 | Infected bed sore | Eggerthella lenta | 83% C jeikeium, 7% Clostridium hastiforme, 7% C histolyticum | >99.9% E lenta | 92% E lenta, 8% A viscosus | E lenta | 0 |
15 | F/85 | Primary bacteraemia | Eubacterium tenue | 81% Propionibacterium granulosum, 13% Actinomyces odontolyticus | 96% Clostridium sordellii, 4% Clostridium bifermentans | 97% A viscosus, 2% E lentum | Clostridium tenue | 1.4 |
16 | F/41 | Primary bacteraemia | Lactobacillus casei/paracasei | Unidentified | Unidentified | 97% Bifidobacterium sp., 3% A israelii | L casei/paracasei | 0 |
17 | M/50 | Primary bacteraemia | Lactobacillus rhamnosus | 50% Lactobacillus jensenii, 46% Actinomyces odontolyticus | >99.9% Lactobacillus acidophilus | 63% A naeslundii, 27% Lactobacillus acidophilus/jensenii | L rhamnosus | 0 |
18 | M/70 | Acute cholecystitis | Lactobacillus salivarius | Unidentified | >99.9% Propionibacterium granulosum | 70% A naeslundii, 30% Bifidobacterium sp. | L salivarius | 0.1 |
19 | M/43 | Acute cholangitis | Olsenella uli | 81% P granulosum, 11% Corynebacterium pseudotuberculosis | Unidentified | 43% Gemella morbillorum, 37% Lactobacillus fermentum, 10% Propionicum/avidum | Atopobium rimae | 11.1 |
20 | F/1 m | Pseudobacteraemia | Propionibacterium acnes | 99.9% P acnes | >99.9% P acnes | 99.9% P acnes | P acnes | 0 |
*In years or months (m).